These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2871564)

  • 1. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.
    Eison AS; Eison MS; Stanley M; Riblet LA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):701-7. PubMed ID: 2871564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
    McMillen BA; Scott SM; Williams HL; Sanghera MK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
    Kehne JH; Cassella JV; Davis M
    Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M; Cassella JV; Kehne JH
    Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats.
    Yamashita S; Oishi R; Gomita Y
    Pharmacol Biochem Behav; 1995 Mar; 50(3):477-9. PubMed ID: 7617689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.
    Yocca FD; Eison AS; Hyslop DK; Ryan E; Taylor DP; Gianutsos G
    Life Sci; 1991; 49(24):1777-85. PubMed ID: 1682780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone.
    Fernández-Guasti A; López-Rubalcava C; Pérez-Urizar J; Castañeda-Hernández G
    Brain Res Bull; 1992 Apr; 28(4):497-501. PubMed ID: 1352175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone].
    Yamamoto T; Shibata S; Teshima K; Inoue Y; Ushio M; Tominaga K; Ohno M; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):41-52. PubMed ID: 1679740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacology of buspirone hydrochloride.
    Skolnick P; Paul SM; Weissman BA
    Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the central serotonergic system in the anticonflict effect of d-AP159.
    Takao K; Nagatani T; Kasahara K; Hashimoto S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):503-8. PubMed ID: 1359579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned taste aversion and place preference with buspirone and gepirone.
    Neisewander JL; McDougall SA; Bowling SL; Bardo MT
    Psychopharmacology (Berl); 1990; 100(4):485-90. PubMed ID: 2320709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations.
    Vivian JA; Farrell WJ; Sapperstein SB; Miczek KA
    Psychopharmacology (Berl); 1994 Feb; 114(1):101-8. PubMed ID: 7846191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
    Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
    Mansbach RS; Geyer MA
    Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.